Prevention of deep vein thrombosis after hip replacement. Comparison between two low-molecular-weight heparins, tinzaparin and enoxaparin

Thrombosis and Haemostasis

Volumn 81, Issue 1, 1999, Pages 22-25

  Planès, André ^a   Samama, Meyer M ^b   Lensing, Anthonie W A ^c   Büller, Harry R ^c   Barre, Jeanne ^d   Vochelle, Nicole ^d   Beau, Bertrand ^e  

^a Clinique Radio Chirurgicale du Mail   (France)

^b HÔTEL DIEU   (France)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d SERVICE DE DERMATOLOGIE   (France)

^e Laboratoires Leo   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICS; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; TOTAL HIP PROSTHESIS;

EID: 0032892273     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614411     Document Type: Article

References (21)

1. Hirsh J, Levine MN. Low-molecular-weight heparin. Blood 1992; 79, 1: 1-17.
2. Barrowcliffe TW, Johnson EA, Thomas DP. Low molecular weight heparin. Eds John Wiley. Chichester 1992.
3. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a metaanalysis. Lancet 1992; 340: 152-6.
4. Leizorovicz A, Haugh MC, Chapuis FR, et al. Low-molecular-weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-20.
5. Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
6. Mätzsch T, Bergqvist D, Fredin H, et al. Comparison of the thromboprophylactic effect of a low-molecular-weight heparin versus dextran in total hip replacement. Thromb Haemorrh Disorders, 1991; 3 (1): 25-9.
7. Lassen MR, Borris LC, Christiansen HM, et al. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand 1991; 62 (1): 33-8.
8. Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-6.
9. Planes A, Vochelle N. Mazas F. et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low-molecular-weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-10.
10. The Danish Enoxaparin Study Group. Low-molecular-weight heparin (Enoxaparin) vs Dextran 70: the prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med 1991; 151: 1621-4.
11. Planes A, Vochelle N, Fagola M et al. Prevention of deep vein thrombosis after total hip replacement, the effect of low-molecular-weight heparin with spinal and general anaesthesia. J Bone Joint Surg 1991; 73 B: 418-22.
12. Spiro TE, Johnson GJ, Christie MJ, et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med 1994; 121, 2:81-9.
13. Planes A. Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery. Blood Coagul Fibrinolysis 1993; 4, suppl 1, S33-5.
14. Eriksson BI, Wille-Jorgensen P, Kälebo P et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997; 337: 1329-35.
15. Elalamy I, Potevin F, Lecrubier C, et al. A fatal low-molecular-weight heparin associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin Elisa test. Blood Coagul and Fibrinolysis 1996; 7: 665-71.
16. Bounameaux H, Prins TR, Schmitt HE et al. Venography of the lower limbs. Pitfalls of the diagnostic standard. Invest Radiol 1992; 27: 1009-11.
17. Lensing AWA, Büller HR, Prandoni P et al. Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: improvement in observer agreement. Thromb Haemost 1992; 67: 8-12.
18. Wille-Jorgensen P, Borris L, Jorgensen N et al. Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation study. Acta Radiologica 1992; 33: 24-8.
19. Couson F, Bounameaux C, Didier D et al. Influence of variability of interpretation of contrast venography for screening of postoperative deep venous thrombosis on the results of a thromboprophylactic study. Thromb Haemost 1993: 70 (4): 573-5.
20. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5.
21. Warkenlin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards a consensus. Thromb Haemost 1998; 79: 1-7.